These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8186135)

  • 21. Treatment costs of three nail lacquers used in onychomycosis.
    Marty JP; Lambert J; Jäckel A; Adjadj L
    J Dermatolog Treat; 2005; 16(5-6):299-307. PubMed ID: 16428149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in onychomycosis after initiation of combined antiretroviral therapy.
    Moreno-Coutiño G; Arenas R; Reyes-Terán G
    Int J Dermatol; 2013 Mar; 52(3):311-3. PubMed ID: 22998739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superficial white onychomycosis of the fingernails in a 1-year-old child with hypoxemia.
    Yamamoto T; Yokoyama A
    Pediatr Dermatol; 2007; 24(1):95-6. PubMed ID: 17300664
    [No Abstract]   [Full Text] [Related]  

  • 24. Proximal white subungual onychomycosis in AIDS.
    Silva-Lizama E; Logemann H
    Int J Dermatol; 1996 Apr; 35(4):290-1. PubMed ID: 8786191
    [No Abstract]   [Full Text] [Related]  

  • 25. Nail involvement in pemphigus vulgaris.
    Schlesinger N; Katz M; Ingber A
    Br J Dermatol; 2002 May; 146(5):836-9. PubMed ID: 12000381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scytalidium infection associated with dyskeratosis congenita.
    Garg J; Tilak R; Gulati AK; Singh S; Prakash P; Garg A
    Br J Dermatol; 2007 Mar; 156(3):604-6. PubMed ID: 17300269
    [No Abstract]   [Full Text] [Related]  

  • 27. Onychomycosis: diagnosis and systemic treatment.
    Milles CL; Riley PA; Kessenich CR
    Nurse Pract; 1998 Dec; 23(12):40-2, 45-8, 51. PubMed ID: 9879077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
    Arikian SR; Einarson TR; Kobelt-Nguyen G; Schubert F
    Br J Dermatol; 1994 Apr; 130 Suppl 43():35-44. PubMed ID: 8186141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differential diagnosis of onychomycosis].
    Richert B; Cappelletti ML; André J
    Rev Med Brux; 2011 Sep; 32(4):219-23. PubMed ID: 22034748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onychomycosis in Cameroon: a clinical and epidemiological study among dermatological patients.
    Nkondjo Minkoumou S; Fabrizi V; Papini M
    Int J Dermatol; 2012 Dec; 51(12):1474-7. PubMed ID: 23171013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onychomycosis in patients with psoriasis.
    Staberg B; Gammeltoft M; Onsberg P
    Acta Derm Venereol; 1983; 63(5):436-8. PubMed ID: 6197846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onychomycosis: updates and management challenges. A review.
    Ayanlowo O; Oladele RO
    Niger Postgrad Med J; 2014 Jun; 21(2):185-91. PubMed ID: 25167597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails.
    Shemer A; Gupta AK; Farhi R; Daigle D; Amichai B
    Br J Dermatol; 2015 Feb; 172(2):380-3. PubMed ID: 25196489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
    Sigurgeirsson B; Ghannoum MA; Osman-Ponchet H; Kerrouche N; Sidou F
    Mycoses; 2016 May; 59(5):319-26. PubMed ID: 26867498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.
    Joish VN; Armstrong EP
    Pharmacoeconomics; 2001; 19(10):983-1002. PubMed ID: 11735669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onychomycosis. Baseline results of an observational study.
    Schein JR; Gause D; Stier DM; Lubeck DP; Bates MM; Fisk R
    J Am Podiatr Med Assoc; 1997 Nov; 87(11):512-9. PubMed ID: 9397656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and mycology of onychomycosis in autoimmune patients.
    Boonchai W; Kulthanan K; Maungprasat C; Suthipinittham P
    J Med Assoc Thai; 2003 Nov; 86(11):995-1000. PubMed ID: 14696780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onychomycosis.
    Zaias N
    Dermatol Clin; 1985 Jul; 3(3):445-60. PubMed ID: 2937586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onycomycosis due to artificial nails.
    Shemer A; Trau H; Davidovici B; Grunwald MH; Amichai B
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):998-1000. PubMed ID: 18355194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective.
    Einarson TR; Arikian SR; Shear NH
    Br J Dermatol; 1994 Apr; 130 Suppl 43():32-4. PubMed ID: 8186140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.